MFC.TO · TOR · Financial Services
Manulife Financial Corporation
Also onConsensus Drift
Implied value per share
CAD 146.60
Market price
CAD 62.06
Implied upside
+136.2%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (CAD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | CAD 79.5bn | CAD 119.3bn | CAD 178.9bn | CAD 268.4bn | CAD 402.6bn | +50.0% |
| EBIT | CAD 156.0m | CAD 234.0m | CAD 351.1m | CAD 526.6m | CAD 789.9m | +50.0% |
| NOPAT | CAD 133.3m | CAD 199.9m | CAD 299.9m | CAD 449.8m | CAD 674.8m | +50.0% |
| Add depreciation & amortisation | CAD -3.8bn | CAD -5.7bn | CAD -8.5bn | CAD -12.8bn | CAD -19.2bn | -50.0% |
| Less capital expenditure | CAD -795.2m | CAD -1.2bn | CAD -1.8bn | CAD -2.7bn | CAD -4.0bn | +50.0% |
| Less increase in working capital | CAD 26.5bn | CAD 39.8bn | CAD 59.6bn | CAD 89.5bn | CAD 134.2bn | -50.0% |
| Free cashflow to firm | CAD 22.0bn | CAD 33.1bn | CAD 49.6bn | CAD 74.4bn | CAD 111.6bn | +50.0% |
| Discount factor | 0.9645 | 0.8973 | 0.8348 | 0.7766 | 0.7225 | - |
| Present value | CAD 21.3bn | CAD 29.7bn | CAD 41.4bn | CAD 57.8bn | CAD 80.6bn | +39.5% |
| Present Value Of The Forecast | CAD 230.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 3.30% | CAD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.839 | Reported 0.759, pulled toward 1.0 (Blume) |
| Cost of equity | 7.91% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.30% | Implied cost of debt of 11.3% is not a credible funding cost, so risk-free + 2bp is assumed instead. Interest expense and reported debt are measuring different things - common for banks, whose interest expense includes deposits that total debt excludes. |
| Market capitalisation | CAD 103.0bn | 87.5% of capital |
| Total debt | CAD 14.7bn | 12.5% of capital, book value as a proxy |
| Tax rate | 14.6% | Effective, capped at statutory |
| WACC | 7.49% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
3% of EV
- Forecast FCFF, final year
- CAD 111.6bn
- Capex at depreciation, working capital in reinvestment
- CAD 674.8m
- Less reinvestment at g/ROIC (24.3% of NOPAT)
- CAD -164.2m
- Capitalised
- CAD 510.6m
- ROIC (reported)
- 10.3%
- Terminal value, undiscounted
- CAD 10.5bn
- Terminal value, discounted
- CAD 7.6bn
- Enterprise value
- CAD 238.4bn
- Less net debt
- CAD -12.0bn
- Equity value
- CAD 250.4bn
Exit at 17.3x EBITDA
-32792% of EV
- Terminal value, undiscounted
- CAD -318.4bn
- Terminal value, discounted
- CAD -230.1bn
- Enterprise value
- CAD 701.6m
- Less net debt
- CAD -12.0bn
- Equity value
- CAD 12.7bn
Spread between methods: 181%.
Sensitivity
Value per share (CAD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.49% | 157.15 | 157.72 | 158.46 | 159.50 | 161.06 |
| 6.49% | 151.36 | 151.64 | 151.98 | 152.41 | 152.99 |
| 7.49% | 146.29 | 146.43 | 146.60 | 146.80 | 147.05 |
| 8.49% | 141.70 | 141.77 | 141.85 | 141.94 | 142.05 |
| 9.49% | 137.46 | 137.49 | 137.52 | 137.56 | 137.60 |
Outlined: this model. Green text: above today's price of 62.06. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 50.0% | 30.4% | -19.6pp |
| EBIT margin | 0.2% | -19.0% | -19.2pp |
| Discount rate | 7.5% | 47.6% | +40.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.